Studies have shown that patients with synovial sarcoma frequently exhibit chromosomal abnormalities, usually involving a translocation between chromosomes X and 18, resulting in the formation of several fusion genes, including SS18-SSX1, SS18-SSX2, and SS18-SSX4. This evidence concerns the gene SSX2 and synovial sarcoma.